Dominique Tytgat
Dominique Tytgat publishes mostly in Organic Chemistry, Molecular Biology and Psychiatry and Mental health, on topics such as Chemical Synthesis and Analysis, Epilepsy research and treatment and Neuroscience and Neuropharmacology Research.
- World rank
- #2,959,348 of 7,710,434 ranked researchers
- Rank in Belgium
- #26,808 of 67,186
- Works
- 25
- Citations
- 675
- Citations per work
- 27.0
What does Dominique Tytgat research?
Dominique Tytgat's work is mostly in Chemistry (28%), Biochemistry, Genetics and Molecular Biology (19%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else833.5%
- Physical Sciences831.8%
- Chemistry727.5%
- Materials Science14.3%
- Life Sciences624.6%
- Health Sciences310.1%
- Medicine310.1%
- 1Organic Chemistry28% of their works
- 2Molecular Biology19% of their works
- 3Psychiatry and Mental health6% of their works
- 4Cellular and Molecular Neuroscience6% of their works
- 5Pediatrics, Perinatology and Child Health4% of their works
- 6Materials Chemistry4% of their works
Research topics
- Chemical Synthesis and Analysis
- Epilepsy research and treatment
- Neuroscience and Neuropharmacology Research
- Synthesis and Reactions of Organic Compounds
- Pharmacological Effects and Toxicity Studies
- Metabolomics and Mass Spectrometry Studies
- Carbohydrate Chemistry and Synthesis
- Synthesis and biological activity
Which keywords describe Dominique Tytgat's research?
The keywords of their largest research topics: Antiepileptic Drugs, Drug Discovery, Peptide Synthesis, Epilepsy, Seizures, Neurotransmission, Oxazolones and Prenatal Exposure.
- Metabolomics
- Mass Spectrometry
- Glycosidase Inhibitors
- Synthesis
- Prenatal Exposure
- Neurotransmission
- Epilepsy
- Drug Discovery
- Antiepileptic Drugs
- Peptide Synthesis
- Seizures
- Oxazolones
- Synaptic Plasticity
- Teratogenicity
- Heterocyclic Compounds
- Medicinal Chemistry
- Oligosaccharide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antiepileptic Drugs72 topics
- Drug Discovery61 topic
- Peptide Synthesis61 topic
- Epilepsy41 topic
- Seizures41 topic
- Neurotransmission31 topic
- Oxazolones31 topic
- Prenatal Exposure31 topic
- Synaptic Plasticity31 topic
- Synthesis31 topic
- Teratogenicity31 topic
- Glycosidase Inhibitors21 topic
- Heterocyclic Compounds21 topic
- Mass Spectrometry21 topic
- Medicinal Chemistry21 topic
- Metabolomics21 topic
- Oligosaccharide Synthesis21 topic
Where does Dominique Tytgat work?
Dominique Tytgat's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Dominique Tytgat have?
OpenAlex counts 25 works and 675 citations for Dominique Tytgat, an h-index of 9, ranking #2,959,348 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dominique Tytgat. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.